Abstract: In some embodiments, the invention includes therapeutic combinations of antiviral active pharmaceutical ingredients and anti-inflammatory active pharmaceutical ingredients, including steroids, and methods of using of the therapeutic compositions in the treatment of viral infections.
Abstract: Disclosed are stable compositions comprising povidone-iodine and a steroid, and methods of making and using such compositions. Also disclosed herein are stable compositions comprising povidone-iodine and an NSAID, and methods of making and using such compositions.
Type:
Application
Filed:
May 11, 2012
Publication date:
February 5, 2015
Applicant:
FORESIGHT BIOTHERAPEUTICS, INC.
Inventors:
Jason Stein, Michael Weiser, Joseph A. Capriotti, Bo Liang, C. Michael Samson
Abstract: The invention includes a preserved ophthalmic preparation comprising povidone-iodine (PVP-I) at a concentration sufficient to preserve the ophthalmic preparation, and at least one member selected from the group consisting of a steroidal anti-inflammatory compound, a non-steroidal anti-inflammatory compound, an antibacterial compound, an anti-allergy compound, and an anti-glaucoma compound. The invention also includes adding PVP-I to an ophthalmic composition in order to preserve the composition, wherein the PVP-I is added at a concentration sufficient to preserve the composition.
Type:
Application
Filed:
May 16, 2013
Publication date:
September 26, 2013
Applicant:
FORESIGHT BIOTHERAPEUTICS, INC.
Inventors:
Bo Liang, Joseph A. Capriotti, C. Michael Samson, Jason Stein, Michael Weiser, Mark Abelson
Abstract: Disclosed are compositions and methods comprising povidone-iodine and a cooling-effective amount of a chemical agent. The compositions are useful to relieve mild ocular irritation, enhance ocular comfort, and to provide a refreshing effect and improved sensation, when the povidone-iodine solution is applied to the eye.
Type:
Application
Filed:
December 15, 2010
Publication date:
July 11, 2013
Applicant:
FORESIGHT BIOTHERAPEUTICS, INC.
Inventors:
Bo Liang, Joseph A. Capriotti, C. Michael Samson, Jason Stein, Michael Weiser
Abstract: Disclosed herein compositions including povidone-iodine (PVP-I) useful in the treatment of acute and chronic bacterial, viral and fungal infections of the internal, middle and external ear of mammals, including humans.
Type:
Application
Filed:
May 8, 2012
Publication date:
April 11, 2013
Applicant:
Foresight Biotherapeutics, Inc.
Inventors:
Joseph A. Capriotti, Bo Liang, C. Michael Samson, Jason Stein, Michael Weiser
Abstract: The invention includes a preserved ophthalmic preparation comprising povidone-iodine (PVP-I) at a concentration sufficient to preserve the ophthalmic preparation, and at least one member selected from the group consisting of a steroidal anti-inflammatory compound, a non-steroidal anti-inflammatory compound, an antibacterial compound, an anti-allergy compound, and an anti-glaucoma compound. The invention also includes adding PVP-I to an ophthalmic composition in order to preserve the composition, wherein the PVP-I is added at a concentration sufficient to preserve the composition.
Type:
Application
Filed:
June 10, 2009
Publication date:
February 2, 2012
Applicant:
Foresight Biotherapeutics, Inc.
Inventors:
Jason Stein, Bo Liang, C. Michael Samson, Joseph A. Capriotti, Michael Weiser, Mark B. Abelson
Abstract: Disclosed herein compositions including povidone-iodine (PVP-I) useful in the treatment of acute and chronic bacterial, viral and fungal infections of the internal, middle and external ear of mammals, including humans.
Type:
Application
Filed:
September 16, 2011
Publication date:
January 5, 2012
Applicant:
Foresight Biotherapeutics, Inc.
Inventors:
Joseph A. Capriotti, Bo Liang, C. Michael Samson, Jason Stein, Michael Weiser
Abstract: Disclosed herein compositions including povidone-iodine (PVP-I) useful in the treatment of acute and chronic bacterial, viral and fungal infections of the internal, middle and external ear of mammals, including humans.
Type:
Application
Filed:
February 27, 2009
Publication date:
October 22, 2009
Applicant:
Foresight Biotherapeutics, Inc.
Inventors:
Joseph A. Capriotti, Bo Liang, C. Michael Samson, Jason Stein, Michael Weiser